There have been a lot of questions about medical care and treatment in the wake of the overturning of Roe v. Wade, the landmark legislation that previously made abortion legal in the U.S. on a federal ...

Ducharme is a contributor to TIME. Ducharme is a contributor to TIME. Soon after she started taking the drug methotrexate in February, Jennifer Crow noticed a significant improvement in her ...

If you’re looking at treatment options for psoriasis, arthritis, or certain kinds of cancer, you may want to learn more about methotrexate. For more details on methotrexate’s uses and more, see this ...

Patients who take methotrexate for a variety of immune-mediated inflammatory diseases and pause taking the drug following receipt of a COVID-19 vaccine dose did not have a higher risk of disease flare ...

Methotrexate falls into the category of disease-modifying antirheumatic drugs, or DMARDs. These drugs do more than deal with symptoms; they actually slow down progression of the disease. About 60 ...

LONG BEACH, Calif. -- Methotrexate, during and after surgery for primary retinal detachment, has produced "amazing" early results in preventing proliferative vitreoretinopathy (PVR), according to ...

Please provide your email address to receive an email when new articles are posted on . “The disease-modifying anti-rheumatic drug methotrexate is the standard-of-care treatment of inflammatory ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — An early, 1-year course of methotrexate may prevent anti-citrullinated protein ...

Methotrexate is a strong drug that could help clear up your psoriasis. It’s part of a class of medications called antimetabolites that stop cells from dividing and slow their growth. In psoriasis, ...

Methotrexate is a strong medicine. The FDA approved it to treat adults with severe, disabling psoriasis that cannot be controlled with medicine applied to the skin or light treatments. Methotrexate ...

Methotrexate is the most frequently used first-line antirheumatic drug. We report the findings of a phase 3 study of monotherapy with tofacitinib, an oral Janus kinase inhibitor, as compared with ...

Methotrexate and cyclosporine are well-known systemic therapies for moderate-to-severe chronic plaque psoriasis. We conduced a randomized, controlled trial comparing methotrexate and cyclosporine in ...